Find uplifting stories about heroes, innovations, and solutions
38 results for "depression treatment"
A major clinical trial shows magnetic seizure therapy treats severe depression as effectively as electroconvulsive therapy, but with far fewer memory problems. This breakthrough could help thousands who avoid current treatments due to cognitive side effects.
Scientists discovered that a single dose of the psychedelic compound DMT produces longer-lasting antidepressant effects in mice than the currently approved rapid-acting treatment S-ketamine. This breakthrough could offer new hope for millions struggling with treatment-resistant depression.
Scientists analyzed over 500 brain scans and discovered that five different psychedelic drugs create remarkably similar patterns of brain activity. This breakthrough could speed up the development of new mental health treatments for depression, anxiety, and addiction.
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
Thousands of people told their depression was "treatment-resistant" found relief when doctors treated their cardiovascular system instead of their brain. The discovery could transform care for the 30% of depression patients who don't respond to traditional medications.
A Mobile health system just introduced a breakthrough brain therapy that helps one in three patients find complete relief from depression, even after traditional treatments failed. The noninvasive option uses magnetic pulses instead of medication.
Massachusetts General Hospital just launched a clinical trial to find out if adding a human "coach" during ketamine therapy makes the treatment work better for depression. The study could reshape how millions access mental health care.
Scientists found that brain cells in young people with depression work overtime when resting but can't keep up under stress. This breakthrough could lead to earlier diagnosis and better treatments for millions struggling with the condition.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
Scientists engineered a new version of the psychedelic compound from magic mushrooms that fights depression without causing hallucinations. Early tests in mice show the modified drug delivers brain benefits while dramatically reducing mind-altering effects.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Scientists tested 12 free, 10-minute online exercises on thousands of adults with depression and found two that genuinely worked a month later. The breakthrough proves mental health support doesn't always require therapy appointments or medication.
Scientists discovered a simple blood marker that predicts which depression patients will respond to the most common antidepressants, potentially sparing millions from months of trying different medications. This breakthrough could transform how doctors treat the 330 million people worldwide living with major depression.
A groundbreaking clinical trial shows one dose of the psychedelic DMT significantly reduced depression symptoms for up to six months. For millions who haven't found relief from traditional treatments, this research opens a promising new door.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
A groundbreaking trial in London shows that DMT, the shortest-acting psychedelic drug, helped nearly half of depression patients feel better within just one week. The fast-acting treatment could transform care by letting patients go home hours after treatment instead of days.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A clinical trial found that one dose of DMT, a natural psychedelic compound, significantly reduced depression symptoms for up to three months. The short treatment session could make mental health care more accessible for millions who don't respond to traditional antidepressants.
A psychedelic treatment could soon offer new hope for people with severe depression who haven't found relief from traditional medicines. Two major clinical trials show the psilocybin therapy helped patients improve more than standard care.
Showing 20 of 38